T2N0M0
Showing 1 - 25 of >10,000
Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Neck Dissection
- Elective neck dissection
- Therapeutic neck dissection
- (no location specified)
Apr 10, 2023
Early Supraglottic Squamous Cell Carcinoma With Advance
Recruiting
- Supraglottic Squamous Cell Carcinoma
- Early Stage (T1-T2, N0-N1,M0)
- TORS
-
Yvoir, Namur, BelgiumCHU UCL Namur
Nov 3, 2022
enVista Toric 0.9D Intraocular Lenses
Recruiting
- Corneal Astigmatism
- enVista Toric
- enVista non-Toric (spherical)
-
Calgary, Alberta, Canada
- +2 more
Nov 9, 2022
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0) Trial in Canada (Whole-body FDG PET-CT
Active, not recruiting
- Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)
- Stage IIb Breast Cancer (T3N0)
- Whole-body FDG PET-CT alone
-
Hamilton, Ontario, Canada
- +5 more
Apr 19, 2022
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
Rectal Cancer Trial in Sabadell (drug, radiation, procedure)
Completed
- Rectal Cancer
- Capecitabine (Xeloda)
- +3 more
-
Sabadell, Barcelona, SpainCorporació Parc Taulí
Nov 15, 2021
Oral Upadacitinib Tablets to Assess Change in Disease Symptoms
Recruiting
- Rheumatoid Arthritis (RA)
-
Edmonton, Alberta, Canada
- +38 more
Jan 17, 2023
Rectal Adenocarcinoma Trial in Baltimore (FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}, Low dose fractionated
Terminated
- Rectal Adenocarcinoma
- FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
- Low dose fractionated radiation therapy (LDFRT)
-
Baltimore, MarylandUmmc Msgcc
Oct 6, 2021
Urothelial Carcinoma Bladder, PD-1 Inhibitor Trial in Shanghai (Tislelizumab, Gemcitabine, Cisplatin)
Recruiting
- Urothelial Carcinoma Bladder
- PD-1 Inhibitor
- Tislelizumab
- +2 more
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 15, 2022
NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- Befotertinib + Icotinib placebo
- Icotinib + Befotertinib placebo
-
Beijing, China
- +2 more
Sep 20, 2023
Cancer, Tumour, Surgery Trial in Canada, United States (Tranexamic acid (TXA), Normal saline)
Active, not recruiting
- Cancer
- +2 more
- Tranexamic acid (TXA)
- Normal saline
-
Rochester, Minnesota
- +10 more
Oct 25, 2022
Osteoarthritis Trial in Canada (ATB-346 low dose, Placebo, ATB-346 mid-dose)
Completed
- Osteoarthritis
- ATB-346 low dose
- +3 more
-
Mission, British Columbia, Canada
- +34 more
Jul 20, 2022
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
Recruiting
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
-
Miami, Florida
- +8 more
Jan 24, 2023
Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)
Recruiting
- Prostate Cancer Metastatic
- Ablative Radiation Therapy
- Standard of care
-
Victoria, British Columbia, Canada
- +14 more
Nov 14, 2022
Respiratory Syncytial Viruses Trial in Canada, United Kingdom, United States (RSVPreF3 OA investigational vaccine, HZ/su
Not yet recruiting
- Respiratory Syncytial Viruses
- RSVPreF3 OA investigational vaccine
- HZ/su vaccine
-
Daphne, Alabama
- +23 more
Jul 21, 2023
Combination Mifepristone/Misoprostol for Medical Abortion
Recruiting
- Medical Abortion
-
Moncton, New Brunswick, Canada
- +6 more
Aug 16, 2022
Disease Activity in Canadian Adult Moderate-to-Severe Atopic
Recruiting
- Atopic Dermatitis
-
Calgary, Alberta, Canada
- +17 more
Jan 17, 2023
Cystic Fibrosis Pulmonary Exacerbation Trial in Canada (Prednisone, Placebos)
Recruiting
- Cystic Fibrosis Pulmonary Exacerbation
- Prednisone
- Placebos
-
Calgary, Alberta, Canada
- +11 more
Nov 23, 2022
Pancreatic Adenocarcinoma Trial in Canada (Gemcitabine, Nab-paclitaxel, Durvalumab)
Active, not recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- +3 more
-
Calgary, Alberta, Canada
- +26 more
May 9, 2022
Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)
Active, not recruiting
- Oropharyngeal Cancer
- Radiation
- Cisplatin
-
Prince George, British Columbia, Canada
- +13 more
Dec 12, 2022